Vaccination adherence to influenza, pneumococcal and hepatitis B virus in adult type 1 diabetes mellitus patients

Moreno-Fernández, Jesús; García-Seco, José Alberto; Rodrigo, Elena María Ortega; Segura, A; García-Seco, Fernando; Muñoz‐Rodríguez, José Ramón

doi:10.1016/j.pcd.2019.09.004

Cited by 10 publications

(7 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In search of solutions for non-compliance of patients with chronic conditions ( 40 ) to vaccination against VPDs, seemingly a global problem ( 41 – 43 ), better implementation and compliance to vaccination program by attending physicians and nurses are imperative ( 44 ). This role was further and highly revealed during the COVID-19 vaccine roll-out ( 45 ).…”

Section: Discussionmentioning

confidence: 99%

Vaccination coverage of patients with type 2 diabetes mellitus: Challenging issues from an outpatient secondary care setting in Greece

Galanos

Dimitriou

Pappas

et al. 2022

Front. Public Health

View full text Add to dashboard Cite

BackgroundIncreased morbidity/mortality due to vaccine preventable diseases (VPD) is encountered in type 2 diabetes (T2D) people. Aim of this study was to assess their vaccination coverage and describe trends possibly affecting compliance.MethodsInformation on vaccination coverage was retrieved from either documents or interview provided by patients, and/or their vaccination record card at a specialized outpatient diabetes center. The selection of the patients was arbitrary.ResultsAn increasing vaccination rate for influenza was observed from 2018 to 2020 among 372 participants. The vaccination coverage for S.pneumoniae was 67.2% (PCV13), 20.4% (PPSV23), 26.3% for herpes zoster in individuals ≥60 years, 1.9% for tetanus-diphtheria-pertussis and 1.1% for hepatitis B. A 10.2% of participants were found to be unvaccinated. Vaccination uptake for influenza and PCV13 was related to age, ≥3 comorbidities and long-term follow-up. T2D individuals consecutively vaccinated for influenza were 3.78 times more likely to be also vaccinated with PCV13.ConclusionsVaccination rates of patients with T2D show an increasing trend, especially for influenza and S. pneumoniae, although the one for S. pneumoniae was low. Older people seem more prone to vaccination, the one for herpes zoster was low with infected patients remaining unvaccinated while significantly low coverage was observed for other VPDs. The findings are important to improve effectiveness of preventative services.

show abstract

Section: Discussionmentioning

confidence: 99%

Vaccination coverage of patients with type 2 diabetes mellitus: Challenging issues from an outpatient secondary care setting in Greece

Galanos

Dimitriou

Pappas

et al. 2022

Front. Public Health

View full text Add to dashboard Cite

show abstract

“…In accordance with other studies, we observed that people over the age of 65 are better vaccinated against influenza and pneumococcal disease. 16,18,[29][30][31] Similarly, an Irish study found coverage rates of 28% against influenza and 16% against pneumococcus in adults at risk below 65 years of age and 60% against influenza and 36% against pneumococcus in adults above the age of 65. 18 It has been suggested that most countries are more devoted to vaccinating older rather than younger risk groups.…”

Section: Discussionmentioning

confidence: 99%

Vaccination coverage of recommended vaccines and determinants of vaccination in at-risk groups

Boey

Bosmans

Ferreira

et al. 2020

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

Upon exposure to vaccine-preventable diseases, certain individuals are at increased risk for complications due to preexisting diseases, age or immunosuppressive treatment. Vaccination against influenza, pneumococcal disease and hepatitis B (for some groups) is advised in addition to standard vaccination against diphtheria, tetanus and pertussis. We estimated the vaccination coverage and determinants of recommended vaccinations in patients with diabetes mellitus type 1 (n = 173) and type 2 (n = 177), chronic kidney disease (CKD) (n = 138), heart failure (n = 200), chronic obstructive pulmonary disease (COPD) (n = 187), HIV (n = 201) or solid organ transplantation (SOT) (n = 201) in a monocentric study. Vaccination data were retrieved from documents provided by patients and general practitioners, and from the Flemish vaccination register. Less than 10% had received all recommended vaccines. Overall, 29% of subjects were vaccinated against diphtheria-tetanus, 10% against pertussis, 44% against influenza, 32% against pneumococcal disease and 24% of HIV patients and 31% of CKD patients against hepatitis B. Age was positively associated with vaccination against influenza (OR:2.0, p < .01) and pneumococcal disease (OR:2.6, p < .001). Patients with COPD, HIV and SOT were more likely to be vaccinated against influenza (OR:2.8, p < .001, OR:1.8, p < .05; OR:2.0, p < .001, respectively) and pneumococcal disease (OR:2.9, p < .001, OR:25.0, p < .001; OR:2.6, p < .001, respectively) than patients with heart failure. Reason for non-vaccination were concerns about effectiveness, necessity and side effects of influenza vaccines, and not being aware of the recommendation for pneumococcal disease. Initiatives to monitor the vaccination status of vulnerable patients are needed, which is why we advocate systematic vaccination registration and frequent communication about vaccination.

show abstract

“…Almost no data are available in the literature on influenza vaccine uptake in this high-risk population. One study carried out in Spain in 2020, on a convenience sample of 300 subjects, reported a 55% influenza vaccination uptake in this population [ 19 ]. To our knowledge, no other recent studies reported influenza coverage data for patients with T1DM.…”

Section: Discussionmentioning

confidence: 99%

“…Despite the strong rationale for recommending influenza immunization to patients with diabetes [ 18 ], available data report that vaccine coverage rates remain low, and below the coverage targets set by health authorities [ 7 , 19 , 20 ]. In addition, influenza immunization coverage data are not routinely collected and monitored for this high-risk population.…”

Section: Introductionmentioning

confidence: 99%

Type 1 Diabetes Patients’ Practice, Knowledge and Attitudes towards Influenza Immunization

et al. 2021

View full text Add to dashboard Cite

Diabetic patients are at higher risk of developing infectious diseases and severe complications, compared to the general population. Almost no data is available in the literature on influenza immunization in people with type 1 diabetes mellitus (T1DM). As part of a broader project on immunization in diabetic patients, we conducted a cross-sectional study to: (i) report on seasonal influenza coverage rates in T1DM patients, (ii) explore knowledge, attitudes, and practices (KAPs) towards seasonal influenza in this population, and (iii) identify factors associated with vaccine uptake, including the role of family doctors and diabetologists. A survey was administered to 251 T1DM patients attending the Diabetes Clinic at San Raffaele Research Hospital in Milan, Italy and individual-level coverage data were retrieved from immunization registries. Self-reported seasonal influenza immunization coverage was 36%, which decreased to 21.7% when considering regional immunization registries, far below coverage target of 75%. More than a third (36.2%) of T1DM patients were classified as pro-vaccine, 30.7% as hesitant, 17.9% as uninformed, and 15.1% as anti-vaccine. Diabetologists resulted to be the most trusted source of information on vaccines’ benefits and risks (85.3%) and should be more actively involved in preventive interventions. Our study highlights the importance of developing tailored vaccination campaigns for people with diabetes, including hospital-based programs involving diabetes specialists.

show abstract

Vaccination adherence to influenza, pneumococcal and hepatitis B virus in adult type 1 diabetes mellitus patients

Cited by 10 publications

References 28 publications

Vaccination coverage of patients with type 2 diabetes mellitus: Challenging issues from an outpatient secondary care setting in Greece

Vaccination coverage of patients with type 2 diabetes mellitus: Challenging issues from an outpatient secondary care setting in Greece

Vaccination coverage of recommended vaccines and determinants of vaccination in at-risk groups

Type 1 Diabetes Patients’ Practice, Knowledge and Attitudes towards Influenza Immunization

Contact Info

Product

Resources

About